Columbus, NC
Peptide Therapy clinics in Columbus
Columbus has an Ohio State University medical overlay and a growing insurance and tech corporate base, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across Dublin, New Albany, Upper Arlington, and the Short North range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the OSU Wexner, OhioHealth, and Nationwide Children's network. The scene here skews toward academic-trained physicians running conservative peptide and HRT practices. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Columbus clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.
No clinics found
Reset all filtersRegulatory context
A note on North Carolina's peptide therapy rules.
Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. The FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list during 2023 and 2024, restricting 503A pharmacy sourcing. Section 503A covers traditional patient-specific compounding; Section 503B covers FDA-registered outsourcing facilities held to cGMP.
-
North Carolina General Statutes Chapter 90 Article 4A (Pharmacy)
Governs pharmacy licensure and compounding under the North Carolina Board of Pharmacy. -
North Carolina General Statutes Chapter 90 Article 1 (Medicine)
Regulates physician prescribing and delegation. -
21 NCAC Chapter 46 (Pharmacy Rules)
Sets compounding standards consistent with USP 795 and 797.
The North Carolina Board of Pharmacy inspects compounding facilities for USP compliance. Non-resident pharmacies shipping peptides into North Carolina must hold a current non-resident permit. The Board publishes public inspection reports and disciplinary actions.
Peptide Therapy in Columbus, answered.
Explore related care